Filters

Innovative clinical trials

Researchers at The George Institute for Global Health, UK, led by Executive Director Professor Otavio Berwanger, are spearheading a programme of work to transform that way we deliver large-scale clinical trials. This programme is borne out of a recognition of the limitations of the ‘traditional’ clinical trial model – and the health gains (social, environmental and economic) – to be had in investigating pragmatic, innovative and efficient approaches. In both the so-called ‘traditional’ and innovative trial models, the gold standard of randomisation controls for both known and unknown confounding factors that could influence trials outcomes, and represents the optimal method to work out whether a healthcare intervention reduces the risk of patient-important outcomes and so inform clinical practice. Where the two models differ is that the traditional approach requires participants be screened and recruited in a trial site by a team of investigators, and so demands both a

Connecting climate, NCDs & women’s health at Women Deliver 2026

News

Prasanthi Attwood

Profile

Prasanthi is an injury epidemiologist focusing on monitoring and evaluation of child road safety projects in 6 countries through the Botnar Foundation and working with longitudinal data to analyse gender differences and injuries amongst a large cohort of adolescents from Vietnam, Peru, Ethiopia and India.

Prasanthi obtained her medical degree from Cambridge University (UK), and then spent over a decade working within the field of injury prevention at Johns Hopkins (Baltimore, US). With a young family and move back to the UK, she wanted to be part of a dynamic and innovative team slightly closer to home and was therefore thrilled to have the opportunity to join the George Institute, UK, helping to further develop the injury research portfolio.

Session 1: Setting the Scene. The burden of childhood burns In Africa

Event

Session 2: Prevention Pathways - From home hazards to safe environments

Event

As the climate changes, how can we protect our food systems and our health?

Podcast

Whistleblower policy

1. About us The George Institute for Global Health, together with its subsidiary companies worldwide (The George Institute or TGI), is committed to the highest standards of conduct and ethical behaviour, research integrity and good corporate governance and to operating: legally and in accordance with applicable legislation and regulations; properly, in accordance with organisational policy and procedures; and ethically, in accordance with recognised ethical principles. Including: supporting Whistleblowers to make reports based on reasonable grounds of Reportable Conduct involving the Institute’s activities, including its scientific research; ensuring that any Whistleblower who makes a report based on reasonable grounds to assist in maintaining the legal, proper and ethical operations of the Institute, can do so: anonymously if they wish; without fear of intimidation, disadvantage or reprisal; and without being penalised in any w

60 Day prescriptions are saving millions. Why aren’t more Australians getting them?

News / Media release

Professor Craig Anderson

Profile

Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia.  

Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Investigator Fellow of the National Health and Medical Research Council (NHMRC) of Australia.  He is a past President of the Asia Pacific Stroke Organisation and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group.  He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.

Dr Maoyi TIAN - 田懋一

Profile

Maoyi Tian is a honorary senior fellow working in The George Institute China. He received his Bachelor of Electronic Engineering from University of York, UK and his MSc of Biomedical Engineering from University of Oxford, UK.

He graduated with his PhD in Biomedical Engineering from University of New South Wales in Sydney, Australia. He is currently a MPhil candidate in Epidemiology in The University of Sydney. His main research focus is using mobile health and health technology for chronic disease management and prevention in the primary care setting, particularly the integration of the mobile health or health technology into the existing health care system.

Experts recommend potassium-enriched low‑sodium salt substitutes to tackle hypertension and heart disease in India

News / Media release

Careers

Make a global impact in your career Are you looking for the next step in your career? An opportunity to make a real difference to people in communities locally and globally? At The George Institute, your work will help find solutions to some of the world’s greatest health challenges.  We are not just a workplace - we are a community united by a shared mission. Joining our global medical research institute means having the opportunity to make a real impact through innovative research, collaboration, and advocacy. As part of our team, you’ll contribute to advancing health equity and play a vital role in improving millions of lives across the world. Naidoc Week Celebrations at The George Institute Australia What we offer Fair pay for allWe are committed to achieving pay equity for all our diverse employees around the world. Wellness mattersYour well-being is our priority, with programs designed to support your mental and emotional health. A susta